HER2, a HER2-targeted immunotherapy, with plans for FDA submission following promising Phase 2b data in osteosarcoma.
India's Bharat Dynamics Limited (BDL) has signed an agreement with the Raytheon and Lockheed Martin-owned Javelin Joint ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback